Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANDES Platform Trial
NCT06452147Recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Jun 2024
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine and bupivacaine in perioperative neurocognitive disorder (3 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Incidence of Neurocognitive Disorders at 7 days. Started Jun 2024; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinebupivacaine
03
Conditions
perioperative neurocognitive disorder
Beyond the preview
Go deeper on NCT06452147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06452147.